盈康生命(300143.SZ):目前暫未與華為醫療大模型開展合作
格隆匯2月19日丨盈康生命(300143.SZ)在投資者互動平台表示,公司目前暫未與華為醫療大模型開展合作。 盈康生命從2021年就佈局“AI+醫療”,目前已引入科大訊飛大模型能力搭建的智能交互平台,在旗下山西盈康一生總醫院正式上線,這是公司在AI醫療領域的創新應用邁入全場景應用新階段的里程碑。未來,盈康生命將繼續以AI+臨牀醫療為驅動,持續探索AI創新應用、推進AI產品研發,打造貫穿用户全週期健康管理的新模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.